Publications by authors named "C S Balch"

Within the tumor microenvironment, myeloid cells constitute a dynamic immune population characterized by a heterogeneous phenotype and diverse functional activities. In this review, we consider recent literature shedding light on the increasingly complex biology of M2-like immunosuppressive tumor-associated macrophages (TAMs), including their contribution to tumor cell invasion and metastasis, stromal remodeling (fibrosis and matrix degradation), and immune suppressive functions, in the tumor microenvironment (TME). This review also delves into the intricate signaling mechanisms underlying the polarization of diverse macrophage phenotypes, and their plasticity.

View Article and Find Full Text PDF
Article Synopsis
  • * A review of literature identified 12 potential vaccines, including promising candidates like SL-V20, HF10, VC2, and mRNA-1608 that are showing strong preclinical results.
  • * Although vaccines such as GEN-003 and HerpV showed initial promise in clinical trials, they haven’t progressed further, but ongoing research is aiming to achieve a breakthrough in HSV prevention and treatment.
View Article and Find Full Text PDF

Cancer-associated fibroblasts (CAFs) are activated fibroblasts that play a role in numerous malignant phenotypes, including hyperproliferation, invasion, and metastasis. These phenotypes correlate with activity of the Hippo pathway oncoprotein, Yes-associated protein-1 (YAP1), and its paralog, transcriptional coactivator with PDZ-binding motif (TAZ). YAP1/TAZ are normally involved in organ growth, under the regulation of various kinases and upon phosphorylation, are retained in the cytoplasm by chaperone proteins, leading to their proteasomal degradation.

View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluated the effectiveness of pegsitacianine, a fluorescent imaging agent, in detecting residual disease after cytoreductive surgery (CRS) in patients with peritoneal carcinomatosis, which could enhance long-term survival chances.
  • - In a phase II trial, 50 patients received pegsitacianine before surgery, and after CRS, 50% of evaluable patients showed residual disease during examination under near-infrared light.
  • - Pegsitacianine was found to be well tolerated, with no serious side effects reported, and helped improve the detection of occult residual disease, indicating its potential utility in surgical procedures.
View Article and Find Full Text PDF

More than 75 years ago, surgeon Ernst Bertner envisioned the Texas Medical Center (TMC) as "breathtaking in the scope and breadth of its conception," that would be "one of the largest in the world"; a gigantic medical enterprise that would "attract the greatest scientists of the world" and would combine patient care, research, and education, on a scale that was "second to none." During the next 3 years, Bertner accomplished important pieces of the Herculean task to bring onto the campus 11 major buildings, including the University of Texas MD Anderson Hospital for Cancer Research, for which he was the interim director. This was an extraordinary accomplishment because at the outset he had only a strategic plan, the deed to 134 acres of forest, and financial support from the MD Anderson Foundation! Bertner further forecasted world-class clinical and educational programs in the TMC, stating: "We envision the time when the Medical Center will become a great magnet, drawing leaders in education, medicine, and dental professions.

View Article and Find Full Text PDF